Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

Conditions

• Major Depressive Disorder

Interventions

• DRUG: Solriamfetol 300 mg
• DRUG: Placebo

Sponsor

Axsome Therapeutics, Inc.